The idea that medical practice should be "evidence-based" may seem like common sense—but the term has sparked a surprisingly intense battle among physicians and health industry stakeholders, Aaron Carroll writes in the New York Times' "The Upshot."
Spark Therapeutics CEO Jeff Marrazzo says the company believes that Luxturna's $850,000 "price reflects the type of life-altering value we're seeing with Luxturna in clinical trials and will allow [Spark] to build on revolutionary science."
CMS says although health care providers are permitted to text certain patient information via secure text messaging platforms, they are not permitted to text patient orders, and instead should use Computerized Provider Order Entry to submit patient orders.
People may be able to detect whether someone is ill simply by looking at the individual's face—a finding that could help people stave off infections and could eventually help physicians improve their diagnoses, according to a new study in Proceedings of the Royal Society B.
Surgeons and medical interventionalists are about as likely as coal miners, construction workers, and others working in physically demanding occupations to develop musculoskeletal disorders, according to a research review published in JAMA Surgery.